Smartphone-Based Measures Can Help ID Frontotemporal Lobar Degeneration
By Elana Gotkine HealthDay Reporter
MONDAY, April 1, 2024 -- Smartphone tests can accurately differentiate individuals with frontotemporal lobar degeneration (FTLD) from controls, according to a study published online April 1 in JAMA Network Open.
Adam M. Staffaroni, Ph.D., from the University of California in San Francisco, and colleagues examined the reliability and validity of smartphone-based cognitive measures for remote FTLD evaluations in a cohort study. During two weeks, controls and participants with FTLD performed smartphone application (app)-based executive functioning tasks and an associated memory task three times. A total of 360 participants were enrolled in the study and divided into discovery and validation cohorts (258 and 102 participants, respectively).
Smartphone tests showed moderate-to-excellent reliability in the participants. The researchers found that the association of smartphone tests with disease severity, criterion-standard neuropsychological tests, and brain volume supported the validity. Individuals with dementia were accurately differentiated from controls by smartphone tests (area under the curve [AUC], 0.93), which were more sensitive to early symptoms (AUC, 0.82) than the Montreal Cognitive Assessment (AUC, 0.68). Highly similar reliability and validity findings were seen in the discovery and validation cohorts. Compared with noncarrier family controls, preclinical participants who harbored pathogenic variants performed significantly worse on three app tasks, but not on a composite of traditional neuropsychological measures.
"The findings of this cohort study, coupled with prior reports indicating that smartphone testing is feasible and acceptable to patients with FTLD, suggest that smartphones may complement traditional in-person research paradigms," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
Warning Letters Can Reduce Quetiapine Overprescribing
MONDAY, April 29, 2024 -- For patients with dementia, letters warning primary care physicians (PCPs) regarding overprescribing can reduce quetiapine prescriptions, according to a...
Nursing Home Staff Shortages Tied to More Inappropriate Antipsychotic Use
FRIDAY, April 26, 2024 -- Nursing homes with staffing shortages have higher inappropriate antipsychotic medication use, particularly among nursing homes in severely deprived...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.